Personalized medicine: new genomics, old lessons

od Offit, Kenneth
Izdano 2011

The Future of Clinical Cancer Genomics

od Offit, Kenneth
Izdano u Semin Oncol (2016)

Heterozygous Mutations in DNA Repair Genes and Hereditary Breast Cancer: A Question of Power

od Ellis, Nathan A., Offit, Kenneth
Izdano 2012

Ethical and Legal Implications of Cancer Genetic Testing: Do Physicians Have a Duty to Warn Patients' Relatives About Possible Genetic Risks?

od Storm, Courtney, Agarwal, Rinki, Offit, Kenneth
Izdano 2008

Association of a HOXB13 Variant with Breast Cancer

od Alanee, Shaheen, Couch, Fergus, Offit, Kenneth
Izdano 2012

Revealing the Incidentalome When Targeting the Tumor Genome

od Bombard, Yvonne, Robson, Mark, Offit, Kenneth
Izdano 2013

Genitourinary Cancers Other than Prostate Cancer in a BRCA-tested Cohort from a Single Institution

od Alanee, Shaheen, Schrader, Kasmintan, Offit, Kenneth
Izdano u Eur Urol (2015)

Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention

od Couch, Fergus J., Nathanson, Katherine L., Offit, Kenneth
Izdano 2014

A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing

od Zhang, Liying, Kirchhoff, Tomas, Yee, Cindy J., Offit, Kenneth
Izdano 2009

Genomic Biomarkers for Breast Cancer Risk

od Walsh, Michael F., Nathanson, Katherine L., Couch, Fergus J., Offit, Kenneth
Izdano u Adv Exp Med Biol (2016)

Cancer Genomics and Inherited Risk

od Stadler, Zsofia K., Schrader, Kasmintan A., Vijai, Joseph, Robson, Mark E., Offit, Kenneth
Izdano u J Clin Oncol (2014)

Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements

od Hayes, James E., Trynka, Gosia, Vijai, Joseph, Offit, Kenneth, Raychaudhuri, Soumya, Klein, Robert J.
Izdano u PLoS One (2015)

Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier

od Alanee, Shaheen, Shah, Sohela, Murali, Rajmohan, Rau-Murthy, Rohini, Schrader, Kasmintan A., Offit, Kenneth
Izdano u Fam Cancer (2013)

Gene Patents and Personalized Cancer Care: Impact of the Myriad Case on Clinical Oncology

od Offit, Kenneth, Bradbury, Angela, Storm, Courtney, Merz, Jon F., Noonan, Kevin E., Spence, Rebecca
Izdano u J Clin Oncol (2013)

A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen)

od Ritter, Deborah I., Rao, Shruti, Kulkarni, Shashikant, Madhavan, Subha, Offit, Kenneth, Plon, Sharon E.
Izdano u Cold Spring Harb Mol Case Stud (2019)

Genetics, Genomics and Cancer Risk Assessment: State of the art and future directions in the era of personalized medicine

od Weitzel, Jeffrey N., Blazer, Kathleen R., MacDonald, Deborah J., Culver, Julie O., Offit, Kenneth
Izdano 2011

Variants at IRX4 as prostate cancer expression quantitative trait loci

od Xu, Xing, Hussain, Wasay M, Vijai, Joseph, Offit, Kenneth, Rubin, Mark A, Demichelis, Francesca, Klein, Robert J
Izdano 2014

Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk

od Kaklamani, Virginia, Yi, Nengjun, Zhang, Kui, Sadim, Maureen, Offit, Kenneth, Oddoux, Carole, Ostrer, Harry, Mantzoros, Christos, Pasche, Boris
Izdano 2011

Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk

od Kaklamani, Virginia G., Sadim, Maureen, Hsi, Alex, Offit, Kenneth, Oddoux, Carole, Ostrer, Harry, Ahsan, Habibul, Pasche, Boris, Mantzoros, Christos
Izdano 2008

Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer

od Alanee, Shaheen, Shah, Sohela, Vijai, Joseph, Schrader, Kasmintan, Rau-Murthy, Rohini, Sarrel, Kara, Manschreck, Christopher, Eastham, James, Offit, Kenneth
Izdano u Fam Cancer (2013)